ARTICLE | Management Tracks
Zentalis co-founder Gallagher now president
Plus DTx hires Huang as CMO and updates from neoX, Altoid and more
June 1, 2022 2:24 AM UTC
Zentalis Pharmaceuticals Inc. (NASDAQ:ZNTL) named company co-founder and Executive Director Cam Gallagher to president. Gallagher was CBO at Immusoft Corp. and serves on the boards of Ocuphire Pharma Inc. (NASDAQ:OCUP), selectION Inc. and Ray Therapeutics Inc. Zentalis is developing small molecules to treat cancer.
RNA-based therapeutics company DTx Pharma Inc. hired Michael Huang as CMO. Huang was CMO at AmMax Bio Inc. and Spruce Biosciences Inc. (NASDAQ:SPRB)...